Loading clinical trials...

COMPLETEDNCT02054273

ADenoVirus Initiative Study in Epidemiology in Germany

The objectives of this study is to assess the characteristics and frequency of adenovirus conjunctivitis in a population of male and female patients from one year of age who present signs and symptoms...

Lead sponsor: NicOx•13 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDPhase 2

Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Viral Conjunctivitis

NCT03749317 · Adenoviral Conjunctivitis

TERMINATEDNA

Viral Conjunctivitis Treatment Study

NCT03861728 · Viral Conjunctivitis

TERMINATEDPhase 2

FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis

NCT00941486 · Acute Adenoviral Conjunctivitis

TERMINATEDPhase 3

Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo

NCT02998541 · Adenoviral Conjunctivitis

COMPLETEDNA

Reducing Adenoviral Patient Infected Days

NCT02472223 · Conjunctivitis, Adenoviral Conjunctivitis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 11, 2017Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment240

Start dateApr 2014

Last updatedJan 11, 2017

Condition

Viral Conjunctivitis

Locations shown

Uwe Pleyer

Berlin

Poliklinik Leiter

Cologne

University eye hospital Freiburg

Freiburg im Breisgau

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 11, 2017Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions